A Randomized Controlled Comparison of Azithromycin and Ofloxacin for Treatment of Multidrug-Resistant or Nalidixic Acid-Resistant Enteric Fever

To examine the efficacy and safety of short courses of azithromycin and ofloxacin for treating multidrug-resistant (MDR, i.e., resistant to chloramphenicol, ampicillin, and cotrimoxazole) and nalidixic acid-resistant enteric fever, azithromycin (1 g once daily for 5 days at 20 mg/kg/day) and ofloxac...

Descripció completa

Guardat en:
Dades bibliogràfiques
Autors principals: Chinh, Nguyen Tran, Parry, Christopher M., Ly, Nguyen Thi, Ha, Huynh Duy, Thong, Mai Xuan, Diep, To Song, Wain, John, White, Nicholas J., Farrar, Jeremy J.
Format: Artigo
Idioma:Inglês
Publicat: American Society for Microbiology 2000
Matèries:
Clinical Therapeutics
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC89974/
https://ncbi.nlm.nih.gov/pubmed/10858343
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars